Tsung-Lin Yang - Related publications

2008 Biomedical Engineering National Taiwan University, London, Taipei City, Taiwan 
NOTE: We are testing a new system for identifying relevant work based on semantic analysis that identifies similarities between recently published papers and the current author's publications. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches.
50 most relevant papers in past 60 days:
Year Citation  Score
2020 Chu C, Shang W, Sun Y, Zhang X. Anlotinib is effective in patients with advanced oral cancer? Medical Hypotheses. 137: 109578. PMID 32001416 DOI: 10.1016/j.mehy.2020.109578   
2020 Jia SN, Wen FX, Gong TT, Li X, Wang HJ, Sun YM, Yang ZC. A review on the efficacy and safety of iodine-125 seed implantation in unresectable pancreatic cancers. International Journal of Radiation Biology. 1-7. PMID 31977258 DOI: 10.1080/09553002.2020.1704300   
2020 Xiang C, Huo M, Ma S, Guo L, Zhao R, Teng H, Zhang J, Han Y. Molecular profiling for supernatants and matched cell pellets of pleural effusions in non-small-cell lung cancer. The Journal of Molecular Diagnostics : Jmd. PMID 32036088 DOI: 10.1016/j.jmoldx.2020.01.011   
2020 Jiang X. Lymphatic vessels, miRNAs, and CAR T cells in tumor immunology. Journal of Zhejiang University. Science. B. 21: 1-2. PMID 31898438 DOI: 10.1631/jzus.B1910003   
2020 Rao M, Oh K, Moffitt R, Thompson P, Li J, Liu J, Sasson A, Georgakis G, Kim J, Choi M, Powers S. Comparative scRNA-seq Reveals Liver Metastasis-Specific Targets in a Patient with Small Intestinal Neuroendocrine Cancer. Cold Spring Harbor Molecular Case Studies. PMID 32054662 DOI: 10.1101/mcs.a004978   
2020 Luo X, Han G, Lu R, Guan S, Wang Y, Ju L, Chen L, Shao J, Bian Z. Transmembrane protein 106C promotes the development of hepatocellular carcinoma. Journal of Cellular Biochemistry. PMID 32037603 DOI: 10.1002/jcb.29678   
2020 Ahn JC, Teng PC, Chen PJ, Posadas E, Tseng HR, Lu SC, Yang JD. Detection of circulating tumor cells and their implications as a novel biomarker for diagnosis, prognostication, and therapeutic monitoring in hepatocellular carcinoma. Hepatology (Baltimore, Md.). PMID 32017145 DOI: 10.1002/hep.31165   
2020 Zeyin R, Zai L, Jianming Z, Tengfei L, Zhonglin Z, Zhilong Y, Zhongmao F, Zhengjun Q, Chen H. GINS4, a prognostic biomarker and reversely mediated by KLF4, promotes the growth of colorectal cancer. Cancer Science. PMID 32012389 DOI: 10.1111/cas.14341   
2020 Zhao S, Zhu H, Jiao R, Wu X, Ji G, Zhang X. Prognostic and clinicopathological significance of SNHG6 in human cancers: a meta-analysis. Bmc Cancer. 20: 77. PMID 32000704 DOI: 10.1186/s12885-020-6530-3   
2020 Sur D, Havasi A, Cainap C, Samasca G, Burz C, Balacescu O, Lupan I, Deleanu D, AlexandruIrimie. Chimeric Antigen Receptor T-Cell Therapy for Colorectal Cancer. Journal of Clinical Medicine. 9. PMID 31936611 DOI: 10.3390/jcm9010182   
2020 Xu M, Guo X, Wang RD, Zhang ZH, Jia YM, Sun X. Long non-coding RNA HANR as a biomarker for the diagnosis and prognosis of colorectal cancer. Medicine. 99: e19066. PMID 32049807 DOI: 10.1097/MD.0000000000019066   
2020 Adashek JJ, Kato S, Ferrara R, Lo Russo G, Kurzrock R. Hyperprogression and Immune Checkpoint Inhibitors: Hype or Progress? The Oncologist. 25: 94-98. PMID 32043794 DOI: 10.1634/theoncologist.2019-0636   
2020 Wan L, Neumann CA, LeDuc PR. Tumor-on-a-chip for integrating a 3D tumor microenvironment: chemical and mechanical factors. Lab On a Chip. PMID 32025687 DOI: 10.1039/c9lc00550a   
2020 Okuno Y, Tanaka R, Mikami K, Takeuchi T. [Renal Cancer Tissue after Nivolumab/Ipilimumab Combination Therapy for Metastatic Renal Cell Carcinoma]. Hinyokika Kiyo. Acta Urologica Japonica. 66: 13-17. PMID 32028750 DOI: 10.14989/ActaUrolJap_66_1_13   
2020 Imai H, Kaira K, Endoh H, Imaizumi K, Goto Y, Kamiyoshihara M, Kosaka T, Yajima T, Ohtaki Y, Osaki T, Kogure Y, Tanaka S, Fujita A, Oyama T, Minato K, et al. Prognostic Significance of Glucose Metabolism as GLUT1 in Patients with Pulmonary Pleomorphic Carcinoma. Journal of Clinical Medicine. 9. PMID 32028659 DOI: 10.3390/jcm9020413   
2020 Dijk F, Veenstra VL, Soer EC, Dings MPG, Zhao L, Halfwerk JB, Hooijer GK, Damhofer H, Marzano M, Steins A, Waasdorp C, Busch OR, Besselink MG, Tol JA, Welling L, et al. Unsupervised class discovery in pancreatic ductal adenocarcinoma reveals cell-intrinsic mesenchymal features and high concordance between existing classification systems. Scientific Reports. 10: 337. PMID 31941932 DOI: 10.1038/s41598-019-56826-9   
2020 Zhou W, Chen H, Ruan Y, Zeng X, Liu F. High Expression of TRIM15 Is Associated with Tumor Invasion and Predicts Poor Prognosis in Patients with Gastric Cancer. Journal of Investigative Surgery : the Official Journal of the Academy of Surgical Research. 1-9. PMID 31906745 DOI: 10.1080/08941939.2019.1705443   
2020 Reuben A, Zhang J, Chiou SH, Gittelman RM, Li J, Lee WC, Fujimoto J, Behrens C, Liu X, Wang F, Quek K, Wang C, Kheradmand F, Chen R, Chow CW, et al. Comprehensive T cell repertoire characterization of non-small cell lung cancer. Nature Communications. 11: 603. PMID 32001676 DOI: 10.1038/s41467-019-14273-0   
2020 Jackson HW, Fischer JR, Zanotelli VRT, Ali HR, Mechera R, Soysal SD, Moch H, Muenst S, Varga Z, Weber WP, Bodenmiller B. The single-cell pathology landscape of breast cancer. Nature. PMID 31959985 DOI: 10.1038/s41586-019-1876-x   
2020 Meng Y, Sun J, Qv N, Zhang G, Yu T, Piao H. Application of molecular imaging technology in tumor immunotherapy. Cellular Immunology. 104039. PMID 32007223 DOI: 10.1016/j.cellimm.2020.104039   
2020 Liu A, Curran MA. Tumor hypermetabolism confers resistance to immunotherapy. Seminars in Cancer Biology. PMID 31982512 DOI: 10.1016/j.semcancer.2020.01.009   
2020 Akbar MW, Isbilen M, Belder N, Canli SD, Kucukkaraduman B, Turk C, Sahin O, Gure AO. A Stemness and EMT Based Gene Expression Signature Identifies Phenotypic Plasticity and is A Predictive but Not Prognostic Biomarker for Breast Cancer. Journal of Cancer. 11: 949-961. PMID 31949498 DOI: 10.7150/jca.34649   
2020 Guo Z, Zeng Y, Chen Y, Liu M, Chen S, Yao M, Zhang P, Zhong F, Jiang K, He S, Yuan G. TRAIP promotes malignant behaviors and correlates with poor prognosis in liver cancer. Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie. 124: 109857. PMID 31972358 DOI: 10.1016/j.biopha.2020.109857   
2020 Wang S, Rong R, Yang DM, Fujimoto J, Yan S, Cai L, Yang L, Luo D, Behrens C, Parra ER, Yao B, Xu L, Wang T, Zhan X, Wistuba II, et al. Computational staining of pathology images to study the tumor microenvironment in lung cancer. Cancer Research. PMID 31915129 DOI: 10.1158/0008-5472.CAN-19-1629   
2020 Kang BJ, Ra SW, Lee K, Lim S, Son SH, Ahn JJ, Kim BC. Circulating Tumor Cell Number Is Associated with Primary Tumor Volume in Patients with Lung Adenocarcinoma. Tuberculosis and Respiratory Diseases. 83: 61-70. PMID 31905433 DOI: 10.4046/trd.2019.0048   
2020 Roelants C, Pillet C, Franquet Q, Sarrazin C, Peilleron N, Giacosa S, Guyon L, Fontanell A, Fiard G, Long JA, Descotes JL, Cochet C, Filhol O. Ex-Vivo Treatment of Tumor Tissue Slices as a Predictive Preclinical Method to Evaluate Targeted Therapies for Patients with Renal Carcinoma. Cancers. 12. PMID 31963500 DOI: 10.3390/cancers12010232   
2020 Abdel-Rahman O, Ghosh S, Walker J. Outcomes of metastatic colorectal cancer patients in relationship to prior and concurrent antibiotics use; individual patient data analysis of three clinical trials. Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico. PMID 32008218 DOI: 10.1007/s12094-020-02301-1   
2020 Hudolin T, Kastelan Z, El-Saleh A, Bakula M, Coric M, Kes P, Tomas D, Basic-Jukic N. Bone morphogenic proteins-2, -4, -6 and 7 in non-muscle invasive bladder cancer. Oncology Letters. 19: 1291-1297. PMID 31966059 DOI: 10.3892/ol.2019.11218   
2020 Mandelker D, Ceyhan-Birsoy O. Evolving Significance of Tumor-Normal Sequencing in Cancer Care. Trends in Cancer. 6: 31-39. PMID 31952779 DOI: 10.1016/j.trecan.2019.11.006   
2020 Egen JG, Ouyang W, Wu LC. Human Anti-tumor Immunity: Insights from Immunotherapy Clinical Trials. Immunity. 52: 36-54. PMID 31940272 DOI: 10.1016/j.immuni.2019.12.010   
2020 Siddiqui BA, Zhang M, Pisters LL, Tu SM. Systemic therapy for primary and extragonadal germ cell tumors: prognosis and nuances of treatment. Translational Andrology and Urology. 9: S56-S65. PMID 32055486 DOI: 10.21037/tau.2019.09.11   
2020 Yamamoto Y, Nishijima-Matsunobu A, Hiroshima Y, Enomoto K, Inoue M, Muto O, Suzuki M, Nanjo H, Shibata H, Omori Y. Two autopsy cases of desmoplastic small round cell tumor. Pathology International. PMID 31944485 DOI: 10.1111/pin.12897   
2020 Chan JCY, Diakos CI, Engel A, Chan DLH, Pavlakis N, Gill A, Clarke SJ. Serum bicarbonate is a marker of peri-operative mortality but is not associated with long term survival in colorectal cancer. Plos One. 15: e0228466. PMID 31999779 DOI: 10.1371/journal.pone.0228466   
2020 Zhu Y, Zou C, Zhang J, Jiang W, Guan F, Tang K, Li S, Li G, Wang J, Ke Z. Dynamically Monitoring the Clonal Evolution of Lung Cancer Based on the Molecular Characterization of Circulating Tumor Cells using Aptamer Cocktail-Modified Nanosubstrates. Acs Applied Materials & Interfaces. PMID 31940177 DOI: 10.1021/acsami.9b22234   
2020 Zhang Z, Li Z, Liu Z, Zhang X, Yu N, Xu Z. Identification of microenvironment-related genes with prognostic value in clear cell renal cell carcinoma. Journal of Cellular Biochemistry. PMID 31961022 DOI: 10.1002/jcb.29654   
2020 Jewett A, Kos J, Kaur K, Safaei T, Sutanto C, Chen W, Wong P, Namagerdi AK, Fang C, Fong Y, Ko MW. Natural Killer Cells: Diverse Functions in Tumor Immunity and Defects in Pre-neoplastic and Neoplastic Stages of Tumorigenesis. Molecular Therapy Oncolytics. 16: 41-52. PMID 31930165 DOI: 10.1016/j.omto.2019.11.002   
2020 Abreu M, Cabezas-Sainz P, Pereira-Veiga T, Falo C, Abalo A, Morilla I, Curiel T, Cueva J, Rodríguez C, Varela-Pose V, Lago-Lestón R, Mondelo P, Palacios P, Moreno-Bueno G, Cano A, et al. Looking for a Better Characterization of Triple-Negative Breast Cancer by Means of Circulating Tumor Cells. Journal of Clinical Medicine. 9. PMID 32012729 DOI: 10.3390/jcm9020353   
2020 Esteban-Rodríguez I, Ruiz Bravo-Burguillos E, Rosas R, Losantos I, Rodríguez-Antolín C, de Castro J. [Protein expression of PD-L1 and clinico-pathological data in a cohort of 53 patients with resectable non small cell lung cancer (NSCLC). Concordance between clones (22C3 and 28-8) and observers. Correlation and prognostic value of clinico-pathological data]. Revista Espanola De Patologia : Publicacion Oficial De La Sociedad Espanola De Anatomia Patologica Y De La Sociedad Espanola De Citologia. 53: 10-18. PMID 31932004 DOI: 10.1016/j.patol.2019.04.003   
2020 Burgess B, Levine B, Taylor RN, Kelly MG. Preoperative Circulating Lymphocyte and Monocyte Counts Correlate with Patient Outcomes in Type I and Type II Endometrial Cancer. Reproductive Sciences (Thousand Oaks, Calif.). PMID 32046381 DOI: 10.1007/s43032-019-00009-4   
2020 Piao L, Li H, Feng Y, Yang Z, Kim S, Xuan Y. SET domain-containing 5 is a potential prognostic biomarker that promotes esophageal squamous cell carcinoma stemness. Experimental Cell Research. 111861. PMID 31981592 DOI: 10.1016/j.yexcr.2020.111861   
2020 Wang Y, Wu D, Wu G, Wu J, Lu S, Lo J, He Y, Zhao C, Zhao X, Zhang H, Wang S. Metastasis-on-a-chip mimicking the progression of kidney cancer in the liver for predicting treatment efficacy. Theranostics. 10: 300-311. PMID 31903121 DOI: 10.7150/thno.38736   
2020 Manna D, Akhtar S, Maiti P, Mondal S, Kumar Mandal T, Ghosh R. Anticancer activity of a 1,4-dihydropyridine in DMBA-induced mouse skin tumor model. Anti-Cancer Drugs. PMID 32011364 DOI: 10.1097/CAD.0000000000000887   
2020 Chen R, Cheng Q, Owusu-Ansah KG, Song G, Jiang D, Zhou L, Xu X, Wu J, Zheng S. NKILA, a prognostic indicator, inhibits tumor metastasis by suppressing NF-κB/Slug mediated epithelial-mesenchymal transition in hepatocellular carcinoma. International Journal of Biological Sciences. 16: 495-503. PMID 32015685 DOI: 10.7150/ijbs.39582   
2020 Ma YY, Shi JJ, Chen JB, Xu KC, Niu LZ. Irreversible electroporation for liver metastasis from pancreatic cancer: A case report. World Journal of Clinical Cases. 8: 390-397. PMID 32047790 DOI: 10.12998/wjcc.v8.i2.390   
2020 Jeong YK, Oh JY, Yoo JK, Lim SH, Kim EH. The Biofunctional Effects of Mesima as a Radiosensitizer for Hepatocellular Carcinoma. International Journal of Molecular Sciences. 21. PMID 32013255 DOI: 10.3390/ijms21030871   
2020 Wang S, Wang X, Zhou X, Lyerly HK, Morse MA, Ren J. DC-CIK as a widely applicable cancer immunotherapy. Expert Opinion On Biological Therapy. PMID 32033522 DOI: 10.1080/14712598.2020.1728250   
2020 Sapudom J, Nguyen KT, Martin S, Wippold T, Möller S, Schnabelrauch M, Anderegg U, Pompe T. Biomimetic tissue models reveal the role of hyaluronan in melanoma proliferation and invasion. Biomaterials Science. PMID 31939453 DOI: 10.1039/c9bm01636h   
2020 Sonai MK, Rastogi S, Madhusudhan KS, Gupta SD, Das P. Clear cell sarcoma like tumor of gastrointestinal tract: Experience of three cases and review of literature. Indian Journal of Pathology & Microbiology. 63: 90-95. PMID 32031130 DOI: 10.4103/IJPM.IJPM_195_19   
2020 Amschler K, Schön MP. Modulating Tumor Cell Functions by Tunable Nanopatterned Ligand Presentation. Nanomaterials (Basel, Switzerland). 10. PMID 31991896 DOI: 10.3390/nano10020212   
2020 Jin J, Lu Z, Wang X, Liu Y, Han T, Wang Y, Wang T, Gan M, Xie C, Wang J, Yu B. E3 ubiquitin ligase TRIM7 negatively regulates NF-kappa B signaling pathway by degrading p65 in lung cancer. Cellular Signalling. 109543. PMID 31958511 DOI: 10.1016/j.cellsig.2020.109543